Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Clinical trial NCT07197307 · RECRUITING

Trial details

NCT number: NCT07197307
Sponsor: Universität Münster
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Aggressive Diffuse Large B-cell Lymphoma High-grade B-cell Lymphoma (HGBL)Follicular Lymphoma (FL) Grade 3B

Start date: 2025-10-31
Primary completion: 2030-04-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.